View in EDS

Multi‐omics integration analysis identifies INPP4B as a T‐cell‐specific activation suppressor.

Saved in:
Bibliographic Details
Title: Multi‐omics integration analysis identifies INPP4B as a T‐cell‐specific activation suppressor.
Authors: Peng, Ting, Fang, Qing, Zhao, Zihao, Chang, Yingjun, Zhao, Xiangyu, Li, Cheng
Source: Clinical & Translational Medicine; Aug2025, Vol. 15 Issue 8, p1-17, 17p
Subject Terms: T cells, T-cell exhaustion, IMMUNOSUPPRESSION, TUMOR microenvironment, PHOSPHATIDYLINOSITOL 3-kinases, MULTIOMICS, DORMANCY (Biology), IMMUNE response
Abstract: Background: Naïve T cells are maintained in a quiescent state prior to activation. As inappropriate T‐cell activation can lead to impaired immune tolerance and autoimmune diseases, the transition from quiescence to activation must be under strict regulation. Despite its importance, the mechanisms underlying the maintenance of the quiescent state remain incompletely understood. Methods and Results: Through multi‐omics integration analysis, we reveal that INPP4B, a phosphatase of the phosphoinositide 3‐kinase pathway, is highly expressed specifically in T cells and is involved in suppressing T‐cell activation and maintaining quiescence. Our findings uncover that INPP4B forms a T‐cell‐specific chromatin interaction domain and exhibits high expression levels in quiescent T cells. Upon T‐cell activation, both the chromatin interaction and expression levels of INPP4B decrease. Functional studies further confirm that INPP4B suppresses T‐cell activation and effector functions. Additionally, we observe increased expression level of INPP4B in exhausted T cells within the tumour microenvironment. Conclusion: These results highlight the importance of maintaining optimal levels of INPP4B for T‐cell function. Our findings suggest that INPP4B could be a potential target for enhancing the efficacy of T‐cell‐mediated immune responses against tumours. Key points: A comprehensive multi‐omics analysis characterizes the expression patterns of INPP4B across immune populations.INPP4B exhibits a T‐cell‐specific expression domain and functions as a T cell activation suppressor.INPP4B is significantly upregulated in exhausted T cells within the tumour microenvironment. [ABSTRACT FROM AUTHOR]
Copyright of Clinical & Translational Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Description
Abstract:Background: Naïve T cells are maintained in a quiescent state prior to activation. As inappropriate T‐cell activation can lead to impaired immune tolerance and autoimmune diseases, the transition from quiescence to activation must be under strict regulation. Despite its importance, the mechanisms underlying the maintenance of the quiescent state remain incompletely understood. Methods and Results: Through multi‐omics integration analysis, we reveal that INPP4B, a phosphatase of the phosphoinositide 3‐kinase pathway, is highly expressed specifically in T cells and is involved in suppressing T‐cell activation and maintaining quiescence. Our findings uncover that INPP4B forms a T‐cell‐specific chromatin interaction domain and exhibits high expression levels in quiescent T cells. Upon T‐cell activation, both the chromatin interaction and expression levels of INPP4B decrease. Functional studies further confirm that INPP4B suppresses T‐cell activation and effector functions. Additionally, we observe increased expression level of INPP4B in exhausted T cells within the tumour microenvironment. Conclusion: These results highlight the importance of maintaining optimal levels of INPP4B for T‐cell function. Our findings suggest that INPP4B could be a potential target for enhancing the efficacy of T‐cell‐mediated immune responses against tumours. Key points: A comprehensive multi‐omics analysis characterizes the expression patterns of INPP4B across immune populations.INPP4B exhibits a T‐cell‐specific expression domain and functions as a T cell activation suppressor.INPP4B is significantly upregulated in exhausted T cells within the tumour microenvironment. [ABSTRACT FROM AUTHOR]
ISSN:20011326
DOI:10.1002/ctm2.70430